
United States · Hospital & health care startup
EchoPixel, Inc. is a healthcare technology company based in Santa Clara, California, founded in 2012.
Funding reportedLast round: Non equity assistance
EchoPixel, Inc. is a healthcare technology company based in Santa Clara, California, founded in 2012.
The company specializes in developing advanced medical visualization software that transforms standard medical images into interactive 3D and 4D holograms. This technology aims to enhance precision health and improve patient care by creating digital twins of patients from standard imaging data. The flagship product, True3D, allows healthcare professionals to visualize and manipulate patient-specific anatomy in an open 3D space without the need for headgear or glasses. EchoPixel also offers Holographic Therapy Guidance (HTG), which provides a 4D interactive experience for intra-operative guidance during minimally invasive surgeries. Their platform supports various applications, including diagnosis, surgical planning, and image-guided procedures, and even enables 3D printing of patient anatomy. EchoPixel serves healthcare providers, particularly surgeons and radiologists, focusing on the HealthTech and Life Sciences sectors.
Funding, as reported
From the SEC filings it signed: 2 on the team.
On the board, as filediAlex B. SeelenbergerAlexei B. Andreev
What they build
Known for
health carereal-time imagingmixed reality in healthcareinformation technology & servicestelemedicinesurgical planningprocedural guidancecongenital heart defect imaginghospital & health care3d visualizationholographic visualizationtranscatheter procedure supporthealthbiotechnologypatient-specific anatomymedical imaging
Built with from their website
PWAGoogle WorkspaceViewport MetaElement UIGoogle MeetGoogle Font APIMobile FriendlyOpen GraphRSSSquarespace
WebSite TonightGoogle AnalyticsVimeoGoDaddy DomainsAmazon AWSHSTSGoDaddy HostingGoogle Search Console
Add your raise, your deck and your story, and put EchoPixel, Inc. in front of investors. Or tell us what we have wrong.